Charles River Laboratories
CRL
286 hedge funds and large institutions have $3.8B invested in Charles River Laboratories in 2016 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 126 increasing their positions, 86 reducing their positions, and 25 closing their positions.
247% more call options, than puts
Call options by funds: $4.51M | Put options by funds: $1.3M
96% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 25
47% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 86
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
8% more funds holding
Funds holding: 264 → 286 (+22)
7% more capital invested
Capital invested by funds: $3.54B → $3.8B (+$261M)
2.73% less ownership
Funds ownership: 100.53% → 97.8% (-2.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$35.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$29M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$22.7M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$15.5M |
| 5 |
RI
Redwood Investments
Boston,
Massachusetts
|
+$14.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
-$53.2M |
| 2 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$28.6M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$24M |
| 4 |
Millennium Management
New York
|
-$22.9M |
| 5 |
SC
Samlyn Capital
New York
|
-$20.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IP
301
Isthmus Partners
Madison,
Wisconsin
| – | -$290K | -3,813 | Closed |
|
|
BIM
302
Bogle Investment Management
Newton Lower Falls,
Massachusetts
| – | -$249K | -3,289 | Closed |
|
303
Walleye Trading
New York
| – | -$122K | -1,600 | Closed |
|
|
OSAM
304
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$104K | -1,374 | Closed |
|
|
TRCT
305
Tower Research Capital (TRC)
New York
| – | -$87K | -1,148 | Closed |
|
|
WAM
306
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | -$6K | -85 | Closed |
|
|
GI
307
Gradient Investments
Arden Hills,
Minnesota
| – | -$6K | -75 | Closed |
|
308
Loomis, Sayles & Company
Boston,
Massachusetts
| – | -$4K | -54 | Closed |
|
|
PIA
309
Piedmont Investment Advisors
Durham,
North Carolina
| – | -$2.05K | -27 | Closed |
|
|
ZB
310
Zions Bancorporation
Salt Lake City,
Utah
| – | +$82 | +1 | New |
|
311
Creative Planning
Overland Park,
Kansas
| – | +$494 | +6 | New |
|
CRL Hedge Fund Activity: Q2 2016 in Review
286 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2016, worth a combined $3.8B — up 7.4% from $3.54B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new CRL positions and 25 closed out — a net gain of 24 holders — while 126 added to existing stakes and 86 trimmed.
The largest buyer was Bank of America, adding an estimated $35.6M. The largest seller was Chartwell Investment Partners, cutting an estimated $53.2M.
- 286 institutional investors held Charles River Laboratories (CRL) as of Q2 2016, up from 264 in Q1 2016.
- Funds reported $3.8B of Charles River Laboratories stock for Q2 2016, up 7.4% quarter-over-quarter.
- 49 funds opened new Charles River Laboratories positions in Q2 2016 and 25 closed out, a net change of +24 holders.
- The largest Charles River Laboratories buyer in Q2 2016 was Bank of America, an estimated $35.6M added.
- The largest Charles River Laboratories seller in Q2 2016 was Chartwell Investment Partners, an estimated $53.2M sold.
Based on aggregated 13F filings for Q2 2016.